A comparative study on the expression of the neural cell adhesion molecule (NCAM) in human neuroblastoma cell lines and tissues was undertaken. NCAMs are a family of closely related cell surface glycoproteins involved in cell-cell interactions. Using antibodies that recognise distinct epitopes on NCAM, their presence was shown in neuroblastoma, but these studies do not yield any information on the specific NCAM isoforms associated with the tumour. Western and Northern blot analyses were therefore carried out to characterise the NCAM isoforms in this neuroectodermal tumour. Western blot studies using the monoclonal antibody ERIC-1 showed that all human neuroblastoma cell lines tested expressed the 140 and 120 kilodalton isoforms of NCAM in their desialo state. Some of the cell lines also expressed NCAM-180. The data are corroborated by Northern blotting where a transcript of 7-4 kilobase pairs was identified only in lines expressing NCAM-180; the 6-7 and 5A4 kilobase pair transcripts coding for 140 and 120 kilodalton isoforms, respectively, were present in all the cell lines tested. The NCAM isoforms identified in neuroblastoma were also different from those found in adult and fetal brain tissue, suggesting that aberrations are expressed in the molecule during tumorigenesis.
NCAMs are a family of closely related glycoproteins described as being involved in cell to cell interactions during growth and development.' The expression of these molecules is widespread in all three germ layers during embryogenesis, but becomes restricted in adults. NCAMs have been described on a variety of human tumours that do not arise from the neuroectoderm. These include rhabdomyosarcoma (Patel K, Kemshead In this paper we extended these observations using both Northern blot and Western blot analysis. All lines and tissues investigated express the embryonic forms of NCAM. After removal of sialic acid residues, however, a heterogeneity in NCAM expression is detected. Furthermore, neuroblastomas seem to express selective isoforms of NCAM compared with human fetal and adult brain.
Methods

CELL LINES
The human neuroblastoma cell lines Kelly,'0 SK-N-BE(2C) (kindly donated by Dr L Helson, New York Medical College), IMR32,"1 SK-N-SH," NB1,'3 GOTO'4 the human neuroepithelioma line CHP100" and the T-cell line GH1'6 were grown in a 5% carbon dioxide incubator using RPMI 1640 medium supplemented with 10% fetal calf serum, 2 mM glutamine, 100 IU/ml penicillin, and 100 ug/ml streptomycin. When approaching confluency, cells were passaged using trypsin/versene to remove adherent neuroblastoma lines from the dishes. All agarose/formaldehyde gel by electrophoresis.
The RNA was transferred to GeneScreen Plus and the filters baked at 80°C for two hours and prehybridised with salmon sperm DNA (0-1 mg/ml) for four hours at 60°C.
Blots were hybridised with a human NCAM cDNA probe (A 9-5 labelled by random priming) at 60°C for 18 hours. Filters were washed to a final stringency of 0 1 x SSC, 1 % sodium dodecyl sulphate at room temperature and exposed to a pre-flashed Fuji x-ray film, with intensifying screens at -70°C for an appropriate period.
SDS-PAGE AND WESTERN BLOT ANALYSIS
Cells were solubilised in sample buffer consisting of 0-1 M TRIS-HCI, pH 6-8, 2% SDS, 10% glycerol, 2 mM PMSF, 2 mM EDTA and 10 ig/ml leupeptin. DNA was sheared by passing the lysate through a series of needles and the lysate boiled for three minutes after addition of dithiothreitol to a final concentration of 0-1 M.
Sodium dodecyl sulphate polycrylamide gel electrophoresis (SDS-PAGE) was performed using a 120 x 140 x 1-5 mm, 7% acrylamide gel at 250 volts for five hours at room temperature. Visible rainbow protein molecular weight markers (corresponding to 14 3- -1 (fig 1) . Similar staining profiles to those reported here were also observed with the human neuroblastoma lines IMR32, SK-N-BE(2C), Kelly and the 5) . This is the pattern of NCAM expression observed in adult brain before neuraminidase treatment, indicating that the molecule is less sialylated. Neuraminidase treatment reduces the size of the five bands, reflecting marginal sialylation ofthese isoforms. observed using a variety of indirect binding assays. Figure 1 shows representative data on the binding of UJ13A and ERIC-1 to three of six neuroblastoma cell lines and one human neuroepithelioma cell line. While there is some variation in the intensity of staining, both within and between cell lines, the signals observed are considerably greater than those observed with leukaemic cell lines such as GH 1 where no fluorescence can be detected by light microscopical examination.
The finding that UJ13A and ERIC-1 antibodies bind to human NCAM has enabled us to investigate what diversity of NCAM expression is found in human neuroblastoma cell lines and tissues. All samples analysed exhibited the embryonic form of the molecule as determined by the degree of smearing shown on the gels. These results were confirmed by a similar staining pattern obtained with a monoclonal antibody recognising polysialic acid (data not shown). Neuraminidase treatment to strip partially carbohydrate residues from proteins showed a heterogeneity in the isoforms ofNCAM expressed on both tumours and tissues. All cell lines expressed the 140 and 120 kilodaltons isoforms of the molecule along with a weak band observed on the gels at 95 kilodaltons. Only the neuroblastoma lines NB1, IMR32, and SK-N-SH express the 180 kilodalton isoform and no expression of the 170 kilodalton protein was detected (fig 2) (table 1) . These results were mimicked by the heterogeneity in NCAM expression in the six stage IV neuroblastomas examined (fig 4) (table 2 ). Furthermore, the data on the human neuroblastoma cell lines were confirmed by Northern blot analysis. In these blots an additional weak band of 5 0 kilobase pairs was observed in some of the cell extracts which has not been reported to code for any of the known isoforms of NCAM. The nature of this band remains unclear, although it has also recently been identified in small cell carcinoma cell lines and tumour tissues (Duilinhoven M, personal communication). Northern blot analysis was not possible for the fresh neuroblastoma samples as they were taken from patients after combination chemotherapy where the quality of the RNA was insufficient for these studies.
The functional importance of the differential expression of NCAM isoforms on neuroblastoma tissue is not clear. Whether this affects their metastatic potential remains unknown.
Unfortunately, due to a lack of tissue, stages I, II, and IVS tumours have not yet been analysed for their differential expression of NCAM isoforms. Cell adhesion depends on the expression of a variety of "adhesion molecules". Recently, it has been shown that NCAM and another adhesion molecule, L1, may work in co-association.25 It is possible that different forms of NCAM exist in particular spatial configurations to maximise association with other molecules and thus influence adhesion.
The diversity of NCAM isoform expression is potentially greater than indicated above. It is known that in some NCAM species differential splicing occurs to allow the insertion of mini-exons into the molecule. For example, a 35 amino acid sequence (designated the MSD1 region) has been described as being inserted specifically in skeletal muscle NCAM between the regions coded for by exons 
